The global Difficile-Associated Diarrhea Treatment Market (Clostridioides difficile infection or CDI) is undergoing a major clinical shift in 2026. Long considered a difficult-to-manage byproduct of heavy antibiotic use in healthcare settings, CDI treatment has evolved from simple antibiotic intervention to a sophisticated landscape involving microbiome restoration and targeted biolog... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/